Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
about
Neuropeptide regulation of the locus coeruleus and opiate-induced plasticity of stress responsesModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionConnecting the pathology of posttraumatic stress and substance use disorders: monoamines and neuropeptides.Stress modulates illness-course of substance use disorders: a translational review.Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinenceThe locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.How does stress lead to risk of alcohol relapse?Continuous in-the-field measurement of heart rate: Correlates of drug use, craving, stress, and mood in polydrug users.A stress-coping profile of opioid dependent individuals entering naltrexone treatment: a comparison with healthy controlsEffects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recoveryAdvances in opioid antagonist treatment for opioid addiction.Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenanceOpioid withdrawal, craving, and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model.Stress enhances retrieval of drug-related memories in abstinent heroin addictsChronic stress, drug use, and vulnerability to addiction.A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphineNeural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependenceStress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use.Translational and reverse translational research on the role of stress in drug craving and relapse.Genetic modulation of plasma NPY stress response is suppressed in substance abuse: association with clinical outcomes.Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humansEvaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidineNovel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.Making a bad thing worse: adverse effects of stress on drug addiction.Effects of sex and remifentanil dose on rats' acquisition of responding for a remifentanil-conditioned reinforcerStress system changes associated with marijuana dependence may increase craving for alcohol and cocaine.Immune system inflammation in cocaine dependent individuals: implications for medications developmentA pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomesModeling relapse situations in the human laboratoryA variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk.A role for dopamine D1-like receptors in acute food deprivation-induced reinstatement of heroin seeking in rats.Stress-related factors in cannabis use and misuse: implications for prevention and treatment.Modeling stress and drug craving in the laboratory: implications for addiction treatment development.Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine.Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers.Incentive learning for morphine-associated stimuli during protracted abstinence increases conditioned drug preference.The association between negative affect and prescription opioid misuse in patients with chronic pain: the mediating role of opioid craving.Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence.Heroin anticraving medications: a systematic review.
P2860
Q26830264-1FAED865-54AC-42D1-BB61-04463ABAA328Q27014154-15EC939D-D612-4946-9834-36BF22DD6102Q30419977-9A5BDC23-C26F-40B7-8C07-D5ABEAF7F089Q30433321-A729D925-9650-42A4-B22E-1B8579606306Q30455336-2099BD79-8799-4A2E-A2B8-B9E0A272639CQ30470629-F08E78D4-9DC4-496B-B524-DEDDC7B1233FQ30616221-0F917CAD-39B5-4082-ACD6-EB6549268307Q33443466-3D7E5F34-A783-469C-985C-8D5919EA1052Q33574825-3F7CDB46-6FBA-445C-8DFC-1B4F0BECFAD5Q33635582-0BD0D051-E4DD-4CA6-AE50-2A928BEE15B1Q34262649-CF8E642E-BA21-46E2-893D-E7F5CCA6D877Q34602839-CFB4D287-CD3F-4C3A-AF5D-3901DD2B8CEDQ34615450-B7BE0A9D-BEF5-47E6-BCA5-4BF60A7AF16DQ34661607-C5199F88-282A-462A-940A-370735750C2AQ34875333-A381E203-B253-4843-9E5D-131DDC2A916CQ34980314-8D3BAD5D-26B6-491E-BF68-44269E660E9DQ35161399-8D41D232-A6C9-410C-A481-40E38D458F41Q35169114-385DF616-C7B1-47DD-B699-E9F94FC2B95AQ35332832-61464EFB-0A63-4556-B793-D3F060E7073AQ35656060-FB4CCAEA-2294-48F0-9156-5B8F5694E055Q35665889-F28852FC-7807-4E7D-A36C-A4BC0A25C234Q36100597-B0AB8B20-39F4-4696-9137-5922180A54A1Q36104010-8E56B227-167B-464C-AE57-1D698398C55EQ36407029-BA109292-42A9-4864-81B0-09875280F7FDQ36655986-9109D4D2-A606-4912-99D9-E379AC7AB12CQ36863128-3F1F07C6-E41C-4B6E-A701-1D8175C9599DQ36908139-F399D738-05DB-4027-A2C2-9CC45D4D0865Q36926561-77C51445-8B14-40C6-A17D-4FF6512F855FQ36950973-84977964-ED8A-4EEC-9D03-33EFBD74E863Q37129579-695C0647-97D2-420C-8FA4-F544739D4EC0Q37182925-DCF96DDD-D535-4708-8730-3BD387B69B25Q37228852-C81DB4B5-CA23-41D5-91F6-C6F956EAB1BDQ37306081-D08ECE61-6322-42FC-BD55-2409E3197D23Q37336685-632884FC-B398-4B4C-BDDA-00493088AF6FQ37352237-BA77FAF6-6524-4144-B02E-1ECB32FCF2E6Q37409565-3415B5E5-ED2E-4578-870F-63AB9F31CF42Q37423491-D29C4F80-791E-4206-A191-75FD563E8C3AQ37677214-CC3C0CB1-0E49-4393-BA32-AB873811CE4EQ37693061-E7D71CFD-0D51-4822-82F1-E81B0FE980F3Q37800930-BF5E61C2-F5CE-49F2-A7F6-001C5E0853C6
P2860
Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Stress and drug-cue-induced cr ...... duals in naltrexone treatment.
@ast
Stress and drug-cue-induced cr ...... duals in naltrexone treatment.
@en
type
label
Stress and drug-cue-induced cr ...... duals in naltrexone treatment.
@ast
Stress and drug-cue-induced cr ...... duals in naltrexone treatment.
@en
prefLabel
Stress and drug-cue-induced cr ...... duals in naltrexone treatment.
@ast
Stress and drug-cue-induced cr ...... duals in naltrexone treatment.
@en
P2093
P2860
P1476
Stress and drug-cue-induced cr ...... duals in naltrexone treatment.
@en
P2093
Cheryl Doebrick
Kwang-Ik A Hong
Rajita Sinha
Scott M Hyman
P2860
P304
P356
10.1037/1064-1297.15.2.134
P577
2007-04-01T00:00:00Z